rs121918197
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_015272.5(RPGRIP1L):c.697A>T(p.Lys233Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015272.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPGRIP1L | NM_015272.5 | c.697A>T | p.Lys233Ter | stop_gained | 6/27 | ENST00000647211.2 | NP_056087.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPGRIP1L | ENST00000647211.2 | c.697A>T | p.Lys233Ter | stop_gained | 6/27 | NM_015272.5 | ENSP00000493946 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251112Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135688
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461464Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727016
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74456
ClinVar
Submissions by phenotype
RPGRIP1L-related disorder Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The RPGRIP1L c.697A>T (p.Lys233Ter) variant is a stop-gained variant that is predicted to result in premature termination of the protein. The p.Lys233Ter variant has been reported in one study in which it is found in one individual with cerebello-oculo-renal syndrome (also known as Joubert syndrome type B) in a compound heterozygous state with a missense variant (Delous et al. 2007). The p.Lys233Ter variant was absent from 260 control chromosomes but is reported at a frequency of 0.00002478 in the total population from the Exome Aggregation Consortium. Due to the potential impact of stop-gained variants and supporting evidence, the p.Lys233Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for RPGRIP1L-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 07, 2024 | The RPGRIP1L c.697A>T variant is predicted to result in premature protein termination (p.Lys233*). This variant has been reported in the compound heterozygous state in individuals with a variety of phenotypes, including Joubert syndrome (Delous et al. 2007. PubMed ID: 17558409), neurodegeneration with brain iron accumulation (NBIA; Martínez-Rubio et al. 2022. PubMed ID: 36233161) and inherited retinal disease (Table S3, Hanany et al. 2020. PubMed ID: 31964843). This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD. Nonsense variants in RPGRIP1L are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change creates a premature translational stop signal (p.Lys233*) in the RPGRIP1L gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1L are known to be pathogenic (PMID: 17558409). This variant is present in population databases (rs121918197, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 17558409). ClinVar contains an entry for this variant (Variation ID: 1068). For these reasons, this variant has been classified as Pathogenic. - |
Joubert syndrome 7 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2007 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 13, 2019 | - - |
Familial aplasia of the vermis Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 20, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at